🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to assess the efficacy and safety of pimecroli...
Status
Completed
Location
Novartis Investigative Site
Start Date
2004-12
Trial ID
NCT00510003
Treatments Being Tested
The purpose of this study is to assess the efficacy and safety of twice dai...
Status
Completed
Location
Cahaba Dermatology
Start Date
2018-12-20
Trial ID
NCT03745638
Treatments Being Tested
The aim of this study is to evaluate whether treatment with a nasal spray b...
Status
Completed
Location
Second University of Naples
Start Date
2012-11
Trial ID
NCT02130440
Treatments Being Tested
Hyaluronic Acid is indicated for the relief of vaginal dryness, itching, an...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2025-03-01
Trial ID
NCT06564883
Treatments Being Tested
The goal of this clinical trial is to determine whether topical tripelennam...
Status
Completed
Location
Palm Beach Atlantic University
Start Date
2025-02-24
Trial ID
NCT07778472
Treatments Being Tested
The scope of this multicenter, double blind, randomized, vehicle-controlled...
Status
Completed
Location
Luca Stingeni
Start Date
2022-10-27
Trial ID
NCT05259774
Treatments Being Tested
The purpose of this research is to study heart rate patterns in people with...
Status
Completed
Location
Facility: Wake Forest University Health Sciences Dermatology
Start Date
2007-03
Trial ID
NCT00691366
The purpose of the study is to evaluate the effect of ruxolitinib cream on ...
Status
Completed
Location
Innovaderm Research Inc.
Start Date
2021-10-12
Trial ID
NCT04839380
Treatments Being Tested
The study is a randomized, double-blind, placebo-controlled study in childr...
Status
Completed
Location
Children's Hospital Los Angeles
Start Date
2014-11-24
Trial ID
NCT02057692
Nalfurafine hydrochloride is a selective kappa-opioid receptor agonist deve...
Status
Completed
Location
Teikyo University School of Medicine
Start Date
2015-09
Trial ID
NCT02659696